Holocene Advisors’s Select Medical SEM Stock Holding History

Holocene Advisors’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-138,912	Closed	-$1.77M	–	938
2022 Q2	$1.77M	Buy	138,912 +22,841	+20%	+$293K	0.01%	578
2022 Q1	$1.5M	Buy	+116,071	New	+$1.53M	0.01%	604
2020 Q1	–	Sell	-56,957	Closed	-$716K	–	814
2019 Q4	$716K	Buy	56,957 +7,170	+14%	+$77.2K	0.01%	605
2019 Q3	$444K	Buy	49,787 +24,677	+98%	+$216K	﹤0.01%	609
2019 Q2	$215K	Buy	25,110 +5,245	+26%	+$41.4K	﹤0.01%	623
2019 Q1	$151K	Buy	+19,865	New	+$160K	﹤0.01%	618
2018 Q4	–	Sell	-18,924	Closed	-$188K	–	804
2018 Q3	$188K	Buy	+18,924	New	+$196K	﹤0.01%	703

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Holocene Advisors's SEM Position: Q3 2022 in Review

Holocene Advisors sold out of Select Medical (SEM) in Q3 2022, closing a stake of 138,912 shares — an estimated $1.77M sold.

Holocene Advisors first reported a position in SEM in Q3 2018 and held it in 7 quarters. The position peaked at $1.77M in Q2 2022. 216 funds tracked by Wall St. Rank hold SEM as of Q3 2022.

Holocene Advisors reported no remaining Select Medical position as of Q3 2022 after selling out during the quarter.
Holocene Advisors sold 138,912 Select Medical shares in Q3 2022, an estimated $1.77M.
Holocene Advisors first reported a position in Select Medical in Q3 2018 and held it in 7 quarters.
Holocene Advisors's Select Medical position peaked at $1.77M in Q2 2022.
216 funds tracked by Wall St. Rank held Select Medical as of Q3 2022.

Based on Holocene Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.